ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 380,74
0,92%
Dow Jones
42 544,22
-0,07%
DAX
19 909,14
-0,25%
Brent Oil
74,825
1,31%
Bitcoin
94 983,16
0,63%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Adma Biologics Inc (ADMA)

  7. Adma Biologics Inc (ADMA) Actualités

ADMA

Adma Biologics (ADMA)

Adma Biologics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ADMA
DateHeureSourceTitreSymboleSociété
20/12/202413h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
20/12/202413h00GlobeNewswire Inc.ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit FacilityNASDAQ:ADMAAdma Biologics Inc
23/11/202403h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
23/11/202403h00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ADMAAdma Biologics Inc
07/11/202423h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADMAAdma Biologics Inc
07/11/202422h05GlobeNewswire Inc.ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
29/10/202421h10GlobeNewswire Inc.ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024NASDAQ:ADMAAdma Biologics Inc
17/09/202413h00GlobeNewswire Inc.ADMA Biologics Set to Join S&P SmallCap 600 IndexNASDAQ:ADMAAdma Biologics Inc
10/09/202413h00GlobeNewswire Inc.ADMA Biologics to Participate in the 2024 Cantor Global Healthcare ConferenceNASDAQ:ADMAAdma Biologics Inc
07/09/202400h43PR Newswire (US)Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600NASDAQ:ADMAAdma Biologics Inc
14/08/202414h59GlobeNewswire Inc.ADMA Biologics Announces Partial Paydown of Revolving Credit FacilityNASDAQ:ADMAAdma Biologics Inc
08/08/202422h05GlobeNewswire Inc.ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
01/08/202413h00GlobeNewswire Inc.ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024NASDAQ:ADMAAdma Biologics Inc
27/07/202403h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
09/05/202422h05GlobeNewswire Inc.ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
09/05/202413h47IH Market NewsU.S. Index Futures Dip, Bank of England Holds Interest Rates at 5.25%NASDAQ:ADMAAdma Biologics Inc
02/05/202413h00GlobeNewswire Inc.ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:ADMAAdma Biologics Inc
11/03/202417h19Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ADMAAdma Biologics Inc
11/03/202412h00GlobeNewswire Inc.ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®NASDAQ:ADMAAdma Biologics Inc
05/03/202413h00GlobeNewswire Inc.ADMA Biologics to Participate in the Raymond James Institutional Investor ConferenceNASDAQ:ADMAAdma Biologics Inc
28/02/202422h10GlobeNewswire Inc.ADMA Biologics Announces CFO TransitionNASDAQ:ADMAAdma Biologics Inc
28/02/202422h05GlobeNewswire Inc.ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
21/02/202422h05GlobeNewswire Inc.ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:ADMAAdma Biologics Inc
21/02/202413h00GlobeNewswire Inc.ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlyticsNASDAQ:ADMAAdma Biologics Inc
14/02/202417h50Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ADMAAdma Biologics Inc
08/01/202413h00GlobeNewswire Inc.ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
18/12/202322h05GlobeNewswire Inc.ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares ManagementNASDAQ:ADMAAdma Biologics Inc
12/12/202313h00GlobeNewswire Inc.ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and OlderNASDAQ:ADMAAdma Biologics Inc
16/11/202313h00GlobeNewswire Inc.ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MDNASDAQ:ADMAAdma Biologics Inc
08/11/202322h05GlobeNewswire Inc.ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:ADMA

Dernières Valeurs Consultées

NYSE
JPM
JP Morgan Chase
EU
BEL20
Bel 20
EU
RNO
Renault
EU
CAP
Capgemini
COIN
ADAUSD
Cardano
NASDAQ
GOOGL
Alphabet
EU
VK
Vallourec
NASDAQ
AMZN
Amazon.com
NASDAQ
MSFT
Microsoft
EU
HO
Thales
EU
PX1
CAC 40
NASDAQ
NVDA
NVIDIA
EU
CS
Axa
COIN
DOGEUSD
Dogecoin
EU
BNP
BNP Paribas
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés